Correlation Between Vincerx Pharma and Pasithea Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Vincerx Pharma and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Pasithea Therapeutics.

Diversification Opportunities for Vincerx Pharma and Pasithea Therapeutics

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vincerx and Pasithea is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Pasithea Therapeutics go up and down completely randomly.

Pair Corralation between Vincerx Pharma and Pasithea Therapeutics

Given the investment horizon of 90 days Vincerx Pharma is expected to generate 196.76 times less return on investment than Pasithea Therapeutics. But when comparing it to its historical volatility, Vincerx Pharma is 17.62 times less risky than Pasithea Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  2.00  in Pasithea Therapeutics Corp on September 12, 2024 and sell it today you would earn a total of  0.50  from holding Pasithea Therapeutics Corp or generate 25.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy51.92%
ValuesDaily Returns

Vincerx Pharma  vs.  Pasithea Therapeutics Corp

 Performance 
       Timeline  
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Pasithea Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma and Pasithea Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma and Pasithea Therapeutics

The main advantage of trading using opposite Vincerx Pharma and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.
The idea behind Vincerx Pharma and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency